PVCTOTCPharmaceutical PreparationsFiscal year ends December 31
PROVECTUS BIOPHARMACEUTICALS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.05+0.00 (+0.39%)
Close on Oct 19, 2026
- Market cap
- $20.55M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Provectus Biopharmaceuticals's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 30, 2026 | Jul 1, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 18, 2026 | Jun 22, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 18, 2026 | Jun 18, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 14, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 30, 2026 | Apr 30, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 20, 2026 | Apr 21, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 26, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 30, 2026 | Feb 2, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 14, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 18, 2025 | Jun 20, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 18, 2025 | Jun 18, 2025 | SEC EDGAR |
| Annual report, amended | 10-K/A | Dec 31, 2024 | May 16, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 14, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 30, 2025 | May 1, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 15, 2025 | Apr 16, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 28, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 15, 2025 | Jan 22, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 20, 2024 | Dec 26, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 5, 2024 | Dec 11, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 2, 2024 | Dec 5, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 14, 2024 | Nov 14, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 14, 2024 | Aug 19, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 13, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 11, 2024 | Jul 17, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 21, 2024 | Jun 25, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 20, 2024 | Jun 21, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 20, 2024 | Jun 20, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 14, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | May 6, 2024 | May 6, 2024 | SEC EDGAR |
| Annual report, amended | 10-K/A | Dec 31, 2023 | Apr 29, 2024 | SEC EDGAR |
| Current report | 8-K | Apr 10, 2024 | Apr 16, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Mar 28, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 21, 2024 | Mar 27, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 25, 2024 | Mar 26, 2024 | SEC EDGAR |
| Current report | 8-K | Feb 22, 2024 | Feb 22, 2024 | SEC EDGAR |
| Current report | 8-K | Feb 15, 2024 | Feb 15, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2023 | Nov 14, 2023 | SEC EDGAR |